Info: Zenodo’s user support line is staffed on regular business days between Dec 23 and Jan 5. Response times may be slightly longer than normal.

There is a newer version of the record available.

Published October 27, 2020 | Version v1
Preprint Open

Detection of toxin-like peptides in plasma and urine samples from COVID-19 patients

  • 1. Craniomed group srl, Montemiletto, Italy
  • 2. European Commission, Joint Research Centre (JRC), Ispra, Italy
  • 3. ISB Ion Source & Biotechnologies srl, Bresso, Italy
  • 4. Department of Medicine and Surgery University of Salerno, Baronissi, Italy
  • 5. European Commission, Joint Research Centre (JRC), Geel, Belgium

Description

SUMMARY

The frequent association between COVID-19 disease and different extrapulmonary clinical manifestations in symptomatic patients was reported recently.

The data reported here suggest an association between COVID-19 disease and the release in the body of (oligo-)peptides almost identical to toxic components of venoms from animals. The presence of these peptides opens new scenarios on the aetiology of the COVID-19 clinical symptoms observed up to now, including neurological manifestations.

Notes

DECLARATION The scientific output expressed does not imply a policy position of the European Commission. Neither the European Commission nor any person acting on behalf of the Commission is responsible for the use that might be made of this publication.

Files

Preprint_Brogna_et_al.pdf

Files (29.9 MB)

Name Size Download all
md5:558c5e929a2bef52ef5bcf53eda35e56
986.0 kB Preview Download
md5:ce0e00e38a0f541719890ebcdaf4d755
28.9 MB Preview Download